Your request to link to rcsb for ACEI-ACE2

• 1O86: crystal structure of human angiotensin converting enzyme in complex with lisinopril. (10.1038/NATURE01370 )
• 1O8A: crystal structure of human angiotensin converting enzyme (native). (10.1038/NATURE01370 )
• 1R42: native human angiotensin converting enzyme-related carboxypeptidase (ace2) (10.1074/JBC.M311191200 )
• 1R4L: inhibitor bound human angiotensin converting enzyme-related carboxypeptidase (ace2) (10.1074/JBC.M311191200 )
• 1UZE: complex of the anti-hypertensive drug enalaprilat and the human testicular angiotensin i-converting enzyme (10.1021/BI049480N )
• 1UZF: complex of the anti-hypertensive drug captopril an the human testicular angiotensin i-converting enzyme (10.1021/BI049480N )
• 2AJF: structure of sars coronavirus spike receptor-binding domain complexed with its receptor (10.1126/SCIENCE.1116480 )
• 2C6F: structure of human somatic angiontensin-i converting enzyme n domain (10.1016/J.JMB.2006.01.048 )
• 2C6N: structure of human somatic angiontensin-i converting enzyme n domain with lisinopril (10.1016/J.JMB.2006.01.048 )
• 2IUL: human tace g13 mutant (10.1021/BI061146Z )
• 2IUX: human tace mutant g1234 (10.1021/BI061146Z )
• 2OC2: structure of testis ace with rxpa380 (10.1074/JBC.M110.167866 )
• 2XY9: human angiotensin converting enzyme in complex with phosphinic tripeptide (10.1042/BJ20102123 )
• 2XYD: human angiotenisn converting enzyme n-domain in complex with phosphinic tripeptide (10.1042/BJ20102123 )
• 2YDM: structural characterization of angiotensin-i converting enzyme in complex with a selenium analogue of captopril (10.1111/J.1742-4658.2011.08276.X )
• 3BKK: tesis ace co-crystal structure with ketone ace inhibitor kaf (10.1021/BI8002605 )
• 3BKL: testis ace co-crystal structure with ketone ace inhibitor kaw 31-mar-10 3bkl 1 title (10.1021/BI8002605 )
• 3D0G: crystal structure of spike protein receptor-binding domain from the 2002-2003 sars coronavirus human strain complexed with human-civet chimeric receptor ace2 (10.1128/JVI.00442-08 )
• 3D0H: crystal structure of spike protein receptor-binding domain from the 2002-2003 sars coronavirus civet strain complexed with human-civet chimeric receptor ace2 (10.1128/JVI.00442-08 )
• 3D0I: crystal structure of spike protein receptor-binding domain from the 2005-2006 sars coronavirus civet strain complexed with human-civet chimeric receptor ace2 (10.1128/JVI.00442-08 )
• 3KBH: crystal structure of nl63 respiratory coronavirus receptor-binding domain complexed with its human receptor (10.1073/PNAS.0908837106 )
• 3L3N: testis ace co-crystal structure with novel inhibitor lisw (10.1042/BJ20100056 )
• 3NXQ: angiotensin converting enzyme n domain glycsoylation mutant (ndom389) in complex with rxp407 (10.1074/JBC.M110.167866 )
• 3SCI: crystal structure of spike protein receptor-binding domain from a predicted sars coronavirus human strain complexed with human receptor ace2 (10.1074/JBC.M111.325803 )
• 3SCJ: crystal structure of spike protein receptor-binding domain from a predicted sars coronavirus civet strain complexed with human receptor ace2 (10.1074/JBC.M111.325803 )
• 3SCK: crystal structure of spike protein receptor-binding domain from a predicted sars coronavirus civet strain complexed with human-civet chimeric receptor ace2 (10.1074/JBC.M111.325803 )
• 3SCL: crystal structure of spike protein receptor-binding domain from sars coronavirus epidemic strain complexed with human-civet chimeric receptor ace2 (10.1074/JBC.M111.325803 )
• 4APH: human angiotensin-converting enzyme in complex with angiotensin-ii (10.1038/SREP00717 )
• 4APJ: human angiotensin-converting enzyme in complex with bppb (10.1038/SREP00717 )
• 4BXK: crystal structure of the angiotensin-1 converting enzyme n-domain in complex with a domain-specific inhibitor (10.1042/CS20130403 )
• 4BZR: human testis angiotensin converting enzyme in complex with k-26 (10.1021/ML4004588 )
• 4BZS: human angiotenisn converting enzyme n-domain in complex with k-26 (10.1021/ML4004588 )
• 4C2N: crystal structure of human testis angiotensin-i converting enzyme mutant e403r (10.1074/JBC.M113.512335 )
• 4C2O: crystal structure of human testis angiotensin-i converting enzyme mutant d465t (10.1074/JBC.M113.512335 )
• 4C2P: crystal structure of human testis angiotensin-i converting enzyme mutant r522k in complex with captopril (10.1074/JBC.M113.512335 )
• 4C2Q: crystal structure of human testis angiotensin-i converting enzyme mutant r522k (10.1074/JBC.M113.512335 )
• 4C2R: crystal structure of human testis angiotensin-i converting enzyme mutant r522q (10.1074/JBC.M113.512335 )
• 4CA5: human angiotensin converting enzyme in complex with a phosphinic tripeptide fi (10.1111/FEBS.12660 )
• 4CA6: human angiotensin converting enzyme n-domain in complex with a phosphinic tripeptide fi (10.1111/FEBS.12660 )
• 4UFA: crystal structure of the angiotensin-1 converting enzyme n-domain in complex with ac-sd (10.1038/SREP13742 )
• 4UFB: crystal structure of the angiotensin-1 converting enzyme n-domain in complex with lys-pro (10.1038/SREP13742 )
• 5AM8: crystal structure of the angiotensin-1 converting enzyme n-domain in complex with amyloid-beta 4-10 (10.1111/FEBS.13647 )
• 5AM9: crystal structure of the angiotensin-1 converting enzyme n-domain in complex with amyloid-beta 10-16 (10.1111/FEBS.13647 )
• 5AMA: crystal structure of the angiotensin-1 converting enzyme n-domain in complex with amyloid-beta 1-16 (10.1111/FEBS.13647 )
• 5AMB: crystal structure of the angiotensin-1 converting enzyme n-domain in complex with amyloid-beta 35-42 (10.1111/FEBS.13647 )
• 5AMC: crystal structure of the angiotensin-1 converting enzyme n-domain in complex with amyloid-beta fluorogenic fragment 4-10 (10.1111/FEBS.13647 )
• 6ACG: trypsin-cleaved and low ph-treated sars-cov spike glycoprotein and ace2 complex, ace2-bound conformation 1 (10.1371/JOURNAL.PPAT.1007236 )
• 6ACJ: trypsin-cleaved and low ph-treated sars-cov spike glycoprotein and ace2 complex, ace2-bound conformation 2 (10.1371/JOURNAL.PPAT.1007236 )
• 6ACK: trypsin-cleaved and low ph-treated sars-cov spike glycoprotein and ace2 complex, ace2-bound conformation 3 (10.1371/JOURNAL.PPAT.1007236 )
• 6CS2: sars spike glycoprotein - human ace2 complex, stabilized variant, all ace2-bound particles (10.1038/S41598-018-34171-7 )
• 6EN5: crystal structure a of the angiotensin-1 converting enzyme n-domain in complex with a diprolyl inhibitor. (10.1021/ACS.JMEDCHEM.7B01478 )
• 6EN6: crystal structure b of the angiotensin-1 converting enzyme n-domain in complex with a diprolyl inhibitor. (10.1021/ACS.JMEDCHEM.7B01478 )
• 6F9R: crystal structure of human angiotensin-1 converting enzyme n-domain in complex with sampatrilat-asp. (10.1111/FEBS.14421 )
• 6F9T: crystal structure of human testis angiotensin-1 converting enzyme in complex with sampatrilat. (10.1111/FEBS.14421 )
• 6F9U: crystal structure of human testis angiotensin-1 converting enzyme in complex with sampatrilat-asp. (10.1111/FEBS.14421 )
• 6F9V: crystal structure of human angiotensin-1 converting enzyme n-domain in complex with sampatrilat. (10.1111/FEBS.14421 )
• 6H5W: crystal structure of human angiotensin-1 converting enzyme c-domain in complex with omapatrilat. (10.1021/ACS.JMEDCHEM.8B01309 )
• 6H5X: crystal structure of human angiotensin-1 converting enzyme n-domain in complex with omapatrilat. (10.1021/ACS.JMEDCHEM.8B01309 )
• 6LZG: structure of novel coronavirus spike receptor-binding domain complexed with its receptor ace2 (10.1016/J.CELL.2020.03.045 )
• 6M0J: crystal structure of sars-cov-2 spike receptor-binding domain bound with ace2 (10.1038/S41586-020-2180-5 )
• 6M17: the 2019-ncov rbd/ace2-b0at1 complex (10.1126/SCIENCE.ABB2762 )
• 6M18: ace2-b0at1 complex (10.1126/SCIENCE.ABB2762 )
• 6M1D: ace2-b0at1 complex, open conformation (10.1126/SCIENCE.ABB2762 )
• 6QS1: crystal structure of human angiotensin-1 converting enzyme n-domain in complex with bppb (10.1042/BCJ20190290 )
• 6TT1: crystal structure of 'res_s2 mutant human angiotensin-1 converting enzyme n-domain in complex with 33re. (10.1042/BCJ20200060 )
• 6TT3: crystal structure of 'res_s2 mutant human angiotensin-1 converting enzyme n-domain in complex with sg6. (10.1042/BCJ20200060 )
• 6TT4: crystal structure of 'res_s2 mutant human angiotensin-1 converting enzyme n-domain in complex with omapatrilat. (10.1042/BCJ20200060 )
• 6VW1: structure of sars-cov-2 chimeric receptor-binding domain complexed with its receptor human ace2 (10.1038/S41586-020-2179-Y )
• 6ZPQ: crystal structure of the open conformation of angiotensin-1 converting enzyme n-domain. (10.1111/FEBS.15601 )
• 6ZPT: crystal structure of the open conformation of s2_s'-mutant human angiotensin-1 converting enzyme n-domain. (10.1111/FEBS.15601 )
• 6ZPU: crystal structure of angiotensin-1 converting enzyme c-domain with inserted symmetry molecule c-terminus. (10.1111/FEBS.15601 )
• 7A91: dissociated s1 domain of sars-cov-2 spike bound to ace2 (non-uniform refinement) (10.1038/S41586-020-2772-0 )
• 7A92: dissociated s1 domain of sars-cov-2 spike bound to ace2 (unmasked refinement) (10.1038/S41586-020-2772-0 )
• 7A94: sars-cov-2 spike glycoprotein with 1 ace2 bound (10.1038/S41586-020-2772-0 )
• 7A95: sars-cov-2 spike glycoprotein with 1 ace2 bound and 1 rbd erect in clockwise direction (10.1038/S41586-020-2772-0 )
• 7A96: sars-cov-2 spike glycoprotein with 1 ace2 bound and 1 rbd erect in anticlockwise direction (10.1038/S41586-020-2772-0 )
• 7A97: sars-cov-2 spike glycoprotein with 2 ace2 bound (10.1038/S41586-020-2772-0 )
• 7A98: sars-cov-2 spike glycoprotein with 3 ace2 bound (10.1038/S41586-020-2772-0 )
• 7C8D: cryo-em structure of cat ace2 and sars-cov-2 rbd (10.1038/S41421-020-00210-9 )
• 7CT5: s protein of sars-cov-2 in complex bound with t-ace2 (10.1038/S41422-020-00438-W )
• 7DF4: sars-cov-2 s-ace2 complex (10.1126/SCIADV.ABE5575 )
• 7DMU: structure of sars-cov-2 spike receptor-binding domain complexed with high affinity ace2 mutant 3n39
• 7KJ2: sars-cov-2 spike glycoprotein with one ace2 bound (10.1038/S41594-020-00549-3 )
• 7KJ3: sars-cov-2 spike glycoprotein with two ace2 bound (10.1038/S41594-020-00549-3 )
• 7KJ4: sars-cov-2 spike glycoprotein with three ace2 bound (10.1038/S41594-020-00549-3 )
• 7KMB: ace2-rbd focused refinement using symmetry expansion of applied c3 for triple ace2-bound sars-cov-2 trimer spike at ph 7.4 (10.1016/J.CHOM.2020.11.004 )
• 7KMS: cryo-em structure of triple ace2-bound sars-cov-2 trimer spike at ph 7.4 (10.1016/J.CHOM.2020.11.004 )
• 7KMZ: cryo-em structure of double ace2-bound sars-cov-2 trimer spike at ph 7.4 (10.1016/J.CHOM.2020.11.004 )
• 7KNB: cryo-em structure of single ace2-bound sars-cov-2 trimer spike at ph 7.4 (10.1016/J.CHOM.2020.11.004 )
• 7KNE: cryo-em structure of single ace2-bound sars-cov-2 trimer spike at ph 5.5 (10.1016/J.CHOM.2020.11.004 )
• 7KNH: cryo-em structure of double ace2-bound sars-cov-2 trimer spike at ph 5.5 (10.1016/J.CHOM.2020.11.004 )
• 7KNI: cryo-em structure of triple ace2-bound sars-cov-2 trimer spike at ph 5.5 (10.1016/J.CHOM.2020.11.004 )